From November 8, 2021 to December 31, 2021, the company has repurchased 1,581,300 shares, representing 2.58% for ¥4,760.13 million. With this, the company has completed the repurchase of 1,581,300 shares, representing 2.58% for ¥4,760.13 million under the buyback announced on November 8, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,623 JPY | +0.09% | -2.43% | -1.31% |
04-29 | AstraZeneca makes progress with Truqap and Enhertu cancer treatments | AN |
04-25 | AstraZeneca upbeat as cancer drugs underpin sales growth | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.31% | 2.33B | |
+13.21% | 8.4B | |
+9.43% | 693M | |
-28.66% | 674M | |
+31.17% | 380M | |
+4.63% | 339M | |
-11.45% | 258M | |
+6.00% | 172M | |
+27.47% | 103M | |
-24.07% | 67.71M |
- Stock Market
- Equities
- 6417 Stock
- News Sankyo Co., Ltd.
- Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 8, 2021.